The impact of VITEK 2 implementation for identification and susceptibility testing of microbial isolates in a Brazilian public hospital

References

1. Andersson M, Östholm-Balkhed Å, Fredrikson M, Holmbom M, Hällgren A et al. Delay of appropriate antibiotic treatment is associated with high mortality in patients with community-onset sepsis in a Swedish setting. Eur J Clin Microbiol Infect Dis 2019; 38:1223–1234 [View Article] [PubMed]
   [Google Scholar]
2. Kumar A, Ellis P, Arabi Y, Roberts D, Light B et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136:1237–1248 [View Article] [PubMed]
   [Google Scholar]
3. Seifert H. The clinical importance of microbiological findings in the diagnosis and management of bloodstream infections. Clin Infect Dis 2009; 48 Suppl 4:S238–45 [View Article] [PubMed]
   [Google Scholar]
4. Febbraro F, Rodio DM, Puggioni G, Antonelli G, Pietropaolo V et al. MALDI-TOF MS versus VITEK^®2: comparison of systems for the identification of microorganisms responsible for bacteremia. Curr Microbiol 2016; 73:843–850 [View Article] [PubMed]
   [Google Scholar]
5. Dubourg G, Lamy B, Ruimy R. Rapid phenotypic methods to improve the diagnosis of bacterial bloodstream infections: meeting the challenge to reduce the time to result. Clin Microbiol Infect 2018; 24:935–943 [View Article] [PubMed]
   [Google Scholar]
6. Monteiro ACM, Fortaleza CMCB, Ferreira AM, Cavalcante R de S, Mondelli AL et al. Comparison of methods for the identification of microorganisms isolated from blood cultures. Ann Clin Microbiol Antimicrob 2016; 15:45 [View Article] [PubMed]
   [Google Scholar]
7. Eigner U, Schmid A, Wild U, Bertsch D, Fahr AM. Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J Clin Microbiol 2005; 43:3829–3834 [View Article] [PubMed]
   [Google Scholar]
8. Bobenchik AM, Hindler JA, Giltner CL, Saeki S, Humphries RM. Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp. J Clin Microbiol 2014; 52:392–397 [View Article] [PubMed]
   [Google Scholar]
9. Zequinao T, Gasparetto J, Oliveira DDS, Silva GT, Telles JP et al. A broad-spectrum beta-lactam-sparing stewardship program in a middle-income country public hospital: antibiotic use and expenditure outcomes and antimicrobial susceptibility profiles. Braz J Infect Dis 2020; 24:221–230 [View Article] [PubMed]
   [Google Scholar]
10. Gasparetto J, Tuon FF, Dos Santos Oliveira D, Zequinao T, Pipolo GR et al. Intravenous-to-oral antibiotic switch therapy: a cross-sectional study in critical care units. BMC Infect Dis 2019; 19:650 [View Article] [PubMed]
    [Google Scholar]
11. Loesch GH, Cruz JAW, Gasparetto J, Oliveira DDS, Telles JP et al. Cost minimization analysis of outpatient parenteral/oral antibiotic therapy at a trauma hospital: Public health system. Infect Control Hosp Epidemiol 2021; 42:1445–1450 [View Article] [PubMed]
    [Google Scholar]
12. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin Infect Dis 2009; 49:1749–1755 [View Article] [PubMed]
    [Google Scholar]
13. Morgan DJ, Malani P, Diekema DJ. Diagnostic stewardship-leveraging the laboratory to improve antimicrobial use. JAMA 2017; 318:607–608 [View Article] [PubMed]
    [Google Scholar]
14. CLSI CaLSI Performance standard for antimicrobial susceptibility - M100-28; 2018
15. EUCAST Clinical breakpoint. European Committee on Antimicrobial Susceptibility Testing Version 11; 2021
16. Roger C, Nucci B, Louart B, Friggeri A, Knani H et al. Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis. J Antimicrob Chemother 2016; 71:208–212 [View Article]
    [Google Scholar]
17. da Costa TM, Cuba GT, Morgado PGM, Nicolau DP, Nouér SA et al. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration. BMC Infect Dis 2020; 20:74 [View Article]
    [Google Scholar]
18. Ramos GP, Rocha JL, Tuon FF. Seasonal humidity may influence Pseudomonas aeruginosa hospital-acquired infection rates. Int J Infect Dis 2013; 17:e757–61 [View Article]
    [Google Scholar]
19. Joyanes P, del Carmen Conejo M, Martínez-Martínez L, Perea EJ. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 2001; 39:3247–3253 [View Article]
    [Google Scholar]
20. Luethy PM, Johnson JK. The use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for the identification of pathogens causing sepsis. J Appl Lab Med 2019; 3:675–685 [View Article]
    [Google Scholar]
21. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W et al. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 2008; 61:428–435 [View Article]
    [Google Scholar]
22. Hamoudi AC, Lin S. Cost analysis of the Auto Microbic system urine identification card. J Clin Microbiol 1981; 14:411–414 [View Article] [PubMed]
    [Google Scholar]